Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer

Por Hu, Meichun, Peng, Shihong, He, Yundong, Qin, Min, Cong, Xiaonan, Xing, Yajing, Liu, Mingyao, Yi, Zhengfang
Publicado no Oncotarget (2015)

Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer

Por Wu, Changping, Jin, Xin, Yang, Jing, Yang, Yinhui, He, Yundong, Ding, Liya, Pan, Yunqian, Chen, Shuai, Jiang, Jingting, Huang, Haojie
Publicado no Oncotarget (2015)

Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer

Por He, Yundong, Lu, Ji, Ye, Zhenqing, Hao, Siyuan, Wang, Liewei, Kohli, Manish, Tindall, Donald J, Li, Benyi, Zhu, Runzhi, Wang, Liguo, Huang, Haojie
Publicado no Nucleic Acids Res (2018)

PubAngioGen: a database and knowledge for angiogenesis and related diseases

Por Li, Peng, Liu, Yongrui, Wang, Huan, He, Yuan, Wang, Xue, He, Yundong, Lv, Fang, Chen, Huaqing, Pang, Xiufeng, Liu, Mingyao, Shi, Tieliu, Yi, Zhengfang
Publicado no Nucleic Acids Res (2014)

Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer

Por He, Yundong, Peng, Shihong, Wang, Jinhua, Chen, Huang, Cong, Xiaonan, Chen, Ang, Hu, Meichun, Qin, Min, Wu, Haigang, Gao, Shuman, Wang, Liguo, Wang, Xin, Yi, Zhengfang, Liu, Mingyao
Publicado no Nat Commun (2016)

PTEN loss promotes intratumoral androgen synthesis and tumor microenvironment remodeling via aberrant activation of RUNX2 in castration-resistant prostate cancer

Por Yang, Yinhui, Bai, Yang, He, Yundong, Zhao, Yu, Chen, Jiaxiang, Ma, Linlin, Pan, Yunqian, Hinten, Michael, Zhang, Jun, Karnes, R. Jeffrey, Kohli, Manish, Westendorf, Jennifer J., Li, Benyi, Zhu, Runzhi, Huang, Haojie, Xu, Wanhai
Publicado no Clin Cancer Res (2017)

Loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion

Por Yang, Yinhui, Blee, Alexandra M., Wang, Dejie, An, Jian, Pan, Yunqian, Yan, Yuqian, Ma, Tao, He, Yundong, Dugdale, Joseph, Hou, Xiaonan, Zhang, Jun, Weroha, S. John, Zhu, Wei-Guo, Wang, Y. Alan, DePinho, Ronald A., Xu, Wanhai, Huang, Haojie
Publicado no Cancer Res (2017)

Intrinsic BET inhibitor resistance in prostate cancer caused by SPOP mutation-mediated BET protein stabilization

Por Zhang, Pingzhao, Wang, Dejie, Zhao, Yu, Ren, Shancheng, Gao, Kun, Ye, Zhenqing, Wang, Shangqian, Pan, Chun-Wu, Zhu, Yasheng, Yan, Yuqian, Yang, Yinhui, Wu, Di, He, Yundong, Zhang, Jun, Lu, Daru, Liu, Xiuping, Yu, Long, Zhao, Shimin, Li, Yao, Lin, Dong, Wang, Yuzhuo, Wang, Liguo, Chen, Yu, Sun, Yinghao, Wang, Chenji, Huang, Haojie
Publicado no Nat Med (2017)

Dual inhibition of AKT‐mTOR and AR signaling by targeting HDAC3 in PTEN‐ or SPOP‐mutated prostate cancer

Por Yan, Yuqian, An, Jian, Yang, Yinhui, Wu, Di, Bai, Yang, Cao, William, Ma, Linlin, Chen, Junhui, Yu, Zhendong, He, Yundong, Jin, Xin, Pan, Yunqian, Ma, Tao, Wang, Shangqian, Hou, Xiaonan, Weroha, Saravut John, Karnes, R Jeffrey, Zhang, Jun, Westendorf, Jennifer J, Wang, Liguo, Chen, Yu, Xu, Wanhai, Zhu, Runzhi, Wang, Dejie, Huang, Haojie
Publicado no EMBO Mol Med (2018)